Quick Takeaways
- BioFortune Inc filed SCHEDULE 13G/A for Connect Biopharma Holdings Ltd Ordinary Shares, par value $0.000174 per share (CNTB).
- Disclosed ownership: 11%.
- Date of event: 31 Dec 2025.
BioFortune Inc - 31 Dec 2025 SCHEDULE 13G/A Report for Connect Biopharma Holdings Ltd Ordinary Shares, par value $0.000174 per share (CNTB)
- Filing Manager
- BioFortune Inc
- Reporting Manager
- Wubin Pan
- Symbol
- CNTB
- Shares outstanding
- 55,803,824 shares
- Disclosed Ownership
- 6,026,813 shares
- Ownership
- 11%
- Form type
- SCHEDULE 13G/A
- Filing time
- 17 Feb 2026, 21:20:41 UTC
- Date of event
- 31 Dec 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"BioFortune Inc disclosed 11% ownership in Connect Biopharma Holdings Ltd Ordinary Shares, par value $0.000174 per share (CNTB) on 31 Dec 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 17 Feb 2026, 21:20.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| BioFortune Inc. | 11% | 5,987,431 | 0 | 5,987,431 | /s/ Wubin Pan | Wubin Pan, Director | |
| Wubin Pan | 11% | 6,026,813 | 0 | 6,026,813 | /s/ Wubin Pan | Wubin Pan |